Inventor

OOST THORSTEN

DE57 patents

⚠️ This page may combine multiple inventors who share the name “OOST THORSTEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OOST THORSTEN

BOEHRINGER INGELHEIM INT

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Cyclic dinucleotide compounds

Modified cyclic dinucleotide compounds

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Substituted 1,2,4-oxadiazoles as TRPA1 inhibitors

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Heterocyclic compounds capable of activating STING

Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

OOST THORSTEN

Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

Pyrazole compounds as CRTH2 antagonists

Substituted oxindole derivatives, medicaments containing said derivatives and use thereof

Substituted oxindole derivatives, drugs containing said derivatives and the use thereof

Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

ANDERSKEWITZ RALF

Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin C

ABBOTT GMBH & CO KG

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

Substituted oxindol derivatives and medicaments containing the same

Substituted oxindole derivatives, drugs containing said derivatives and the use thereof

Substituted oxindole derivatives, medicaments containing said derivatives and use thereof

LUBISCH WILFRIED

Substituted oxindole derivatives, medicaments containing the latter and use thereof

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

Substituted oxindole derivatives, medicaments containing the latter and use thereof

Substituted oxindole derivatives and medicaments containing the same

ABBVIE DEUTSCHLAND

5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases

Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases

Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

NETZ ASTRID

Substituted oxindole derivatives and their use as vasopressin receptor ligands

Substituted oxindole derivatives and their use as vasopressin receptor ligands

Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases

BRAJE WILFRIED

5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases

Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases

ABBOTT LAB

N-acylsulfonamide apoptosis promoters

N-acylsulfonamide apoptosis promoters

ARNDT TORSTEN

Substituted benzimidazolone derivatives, medicaments comprising them and their use

Substituted benzimidazolone derivatives, medicaments comprising them and their use

GRUNDL MARC

Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C

GRAUERT MATTHIAS

Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

GNAMM CHRISTIAN

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

MARTYRES DOMNIC

Pyrazole compounds as CRTH2 antagonists

GENESTE HERVE

Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands